<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02566343</url>
  </required_header>
  <id_info>
    <org_study_id>PV4743</org_study_id>
    <nct_id>NCT02566343</nct_id>
  </id_info>
  <brief_title>Preoperative Diagnostic Tests for Pulmonary Risk Assessment in COPD</brief_title>
  <acronym>PredicT</acronym>
  <official_title>Preoperative Diagnostic Tests for Pulmonary Risk Assessment in Patients With Chronic Obstructive Pulmonary Disease (COPD) Undergoing Major Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitätsklinikum Hamburg-Eppendorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This prospective study intends to investigate the incidence of postoperative pulmonary&#xD;
      complications (PPC) or in-hospital mortality in patients with COPD or at risk for COPD&#xD;
      undergoing high-risk noncardiac major surgery and to identify relevant risk factors. This&#xD;
      study aims to quantify and compare the diagnostic performance of preoperative functional&#xD;
      tests, exercise capacity, clinical assessment tests and predictive scoring systems to predict&#xD;
      PPC or in-hospital mortality in these patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      COPD is associated with high perioperative morbidity and mortality and PPC frequently occur&#xD;
      in these patients. However, concepts for preoperative pulmonary risk assessment and the&#xD;
      predictive value of routine preoperative exercise capacity, clinical assessment and pulmonary&#xD;
      function tests are still poorly characterized.&#xD;
&#xD;
      Objectives:&#xD;
&#xD;
        -  To determine the incidence of the composite end point of PPC or all cause in-hospital&#xD;
           mortality in patients with confirmed COPD (spirometry) and patients with clinical risk&#xD;
           factors in whom spirometry disproved COPD.&#xD;
&#xD;
        -  To determine the predictive value of exercise capacity, clinical assessment tests,&#xD;
           pulmonary function tests and predictive scoring systems to predict the composite end&#xD;
           point in these patients.&#xD;
&#xD;
        -  To identify relevant risk factors and predictors associated with the composite end&#xD;
           point.&#xD;
&#xD;
      Methodology:&#xD;
&#xD;
      Prospective single-centre observational study&#xD;
&#xD;
      All patients receive a structured preoperative pulmonary risk assessment with:&#xD;
&#xD;
        1. standardized clinical questionnaire&#xD;
&#xD;
        2. COPD Assessment Test (CAT™)&#xD;
&#xD;
        3. exercise capacity (symptom-limited stair climbing)&#xD;
&#xD;
        4. spirometry&#xD;
&#xD;
        5. capillary blood gas Analysis&#xD;
&#xD;
      Postoperative follow-up is planned between the 2nd and 5th day after extubation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2014</start_date>
  <completion_date type="Actual">July 2016</completion_date>
  <primary_completion_date type="Actual">July 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Composite end point of postoperative pulmonary complications (PPC) or all cause in-hospital mortality</measure>
    <time_frame>until hospital discharge up to 6 months after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Forced expiratory volume in one second to forced vital capacity ratio (FEV1/FVC) and FEV1 % predicted</measure>
    <time_frame>within 1 week after extubation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Carbon dioxide (pCO2) and oxygen (pO2) partial pressures from blood gas analysis</measure>
    <time_frame>within 1 week after extubation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative new respiratory symptoms (e.g. dyspnea or wheezing) or treatment for exacerbation (e.g. new systemic glucocorticosteroids or bronchodilators)</measure>
    <time_frame>until hospital discharge up to 6 months after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>New pulmonary radiological findings (e.g. pneumonia or pneumothorax)</measure>
    <time_frame>until hospital discharge up to 6 months after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of hospitalization (days)</measure>
    <time_frame>until hospital discharge up to 6 months after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of postoperative respirator support (h)</measure>
    <time_frame>until hospital discharge up to 6 months after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay in the intensive care unit (days)</measure>
    <time_frame>until hospital discharge up to 6 months after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of unplanned intensive care unit admission, prolonged oxygen requirement, reintubation, non-invasive ventilation (NIV) or extracorporeal lung assist</measure>
    <time_frame>until hospital discharge up to 6 months after surgery</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">365</enrollment>
  <condition>Lung Diseases, Obstructive</condition>
  <condition>Postoperative Complications</condition>
  <arm_group>
    <arm_group_label>COPD cohort</arm_group_label>
    <description>confirmed COPD: 240 patients with COPD confirmed by spirometry undergoing high-risk noncardiac major surgery in the University Medical Center Hamburg-Eppendorf will be included in this group.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control cohort</arm_group_label>
    <description>disproved COPD: 80 patients without COPD (clinical risk factors but negative spirometry) undergoing high-risk noncardiac major surgery will be included as a control group.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients scheduled for major surgery, who present in the pre-assessment clinic of the&#xD;
        University Medical Center Hamburg-Eppendorf during the study recruitment period, will be&#xD;
        screened for eligibility. Patients with typical clinical signs and a positive COPD&#xD;
        Assessment Test (CAT™) qualify for spirometry. After informed consent 80 patients with&#xD;
        disproved COPD (FEV1/FVC ratio ≥ 0.70) and 240 patients with confirmed COPD (FEV1/FVC ratio&#xD;
        &lt; 0.70) will consecutively be analysed.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years and older&#xD;
&#xD;
          -  High-risk noncardiac major surgery with an anticipated operation time ≥ 120 minutes&#xD;
             and/or planned postoperative intensive care unit admission&#xD;
&#xD;
          -  Typical clinical signs for COPD (dyspnea, chronic cough, chronic sputum production,&#xD;
             exposure to risk factors)&#xD;
&#xD;
          -  Confirmed COPD (medical history) or clinical risk factors for COPD&#xD;
&#xD;
          -  Positive COPD Assessment Test (CAT™)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  &lt; 18 Years&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Lack of cooperation&#xD;
&#xD;
          -  Inability to provide functional tests like spirometry or stairclimbing&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin Petzoldt, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitätsklinikum Hamburg-Eppendorf</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christian Zöllner, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitätsklinikum Hamburg-Eppendorf</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Gupta H, Ramanan B, Gupta PK, Fang X, Polich A, Modrykamien A, Schuller D, Morrow LE. Impact of COPD on postoperative outcomes: results from a national database. Chest. 2013 Jun;143(6):1599-1606. doi: 10.1378/chest.12-1499.</citation>
    <PMID>23287892</PMID>
  </reference>
  <verification_date>June 2016</verification_date>
  <study_first_submitted>September 21, 2015</study_first_submitted>
  <study_first_submitted_qc>October 1, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 2, 2015</study_first_posted>
  <last_update_submitted>June 23, 2020</last_update_submitted>
  <last_update_submitted_qc>June 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Spirometry</keyword>
  <keyword>Exercise Test</keyword>
  <keyword>Blood Gas Analysis</keyword>
  <keyword>Respiratory Function Tests</keyword>
  <keyword>Diagnostic Techniques, Respiratory System</keyword>
  <keyword>Surgical Procedures, Operative</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

